跳至主要内容
临床试验/EUCTR2017-003836-35-ES
EUCTR2017-003836-35-ES进行中(未招募)1 期

Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) - COP-AF

Population Health Research Institute0 个研究点目标入组 2,800 人开始时间: 2018年6月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
2,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All patients undergoing thoracic surgery with general anesthesia are eligible for the trial if they are =55 years of age at the time of randomization.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 980
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1820

排除标准

  • We will exclude patients who meet any of the following criteria:
  • 1.Patients with a prior history of documented AF;
  • 2.Patients currently taking anti-arrhythmic medication;
  • 3.Patients undergoing minor thoracic interventions/procedures;
  • 4.Patients with contraindications to colchicine;
  • 5.Patients not expected to take oral medications for >24 hours after surgery;
  • 6.Patients scheduled for lung transplantation;
  • 7.Patients currently taking non-study colchicine before surgery;
  • 8.Patients with severe hepatic dysfunction;
  • 9.Patients with aplastic anemia,
  • 10.Women of childbearing age who are not taking an effective form of birth control,
  • 11.Patients who took within the last 14 days or scheduled to take during the first 10 days after surgery clarithromycin, erythromycin, telithromycin, cyclosporine, ketoconazole or itraconazole; OR
  • 12.HIV patients treated with antiretroviral therapy.

研究者

相似试验